Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gore Excluder AAA System Approved; Physician Training Plans Under Way

This article was originally published in The Gray Sheet

Executive Summary

W.L. Gore & Associates' Excluder bifurcated endoprosthesis is the third minimally invasive device for repair of abdominal aortic aneurysms to reach the U.S. market

You may also be interested in...



New Products In Brief

Approvals and launches from Navidea Biopharmacueticals, Alphatec and more.

Gore’s Excluder AAA Endoprosthesis Is Approvable With Conditions – Panel

The safety profile and anticipated clinical benefits of W.L. Gore & Associates' Excluder bifurcated endoprosthesis justify approval of the device even though the clinical study's primary effectiveness endpoint was not met, FDA's Circulatory System Devices Panel concluded Sept. 9

Circulatory Panel’s September Agenda Includes AAA Device Review

W.L. Gore hopes to receive premarket approval for its Excluder abdominal aortic aneurysm repair system by year-end

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017448

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel